Published: Jul 2, 2026
Written by Klarity Editorial Team
Published: Jul 2, 2026

If you’re a psychiatrist or psychiatric nurse practitioner exploring telehealth, one question dominates: Can I legally prescribe medications—including controlled substances—to patients I see remotely? The short answer is yes, in most cases. But the longer, more accurate answer depends on your state, your provider type, and whether you’re prescribing stimulants, benzodiazepines, or other controlled meds.
Telepsychiatry has gone from ’emergency workaround’ during COVID to a permanent fixture of mental healthcare. As of 2026, federal waivers still allow prescribing controlled substances via telehealth without an initial in-person visit—extended through at least December 31, 2025. But state laws add layers of complexity, especially for PMHNPs navigating scope-of-practice restrictions.
This guide cuts through the confusion. We’ll cover what psychiatrists and PMHNPs can prescribe via telehealth, how state rules differ, and what you need to know to stay compliant while scaling your practice.
Let’s start with the big picture. Under the Ryan Haight Act (2008), prescribing Schedule II–V controlled substances requires at least one in-person medical evaluation. That law was written to prevent online pill mills, but it also created a barrier for legitimate telemedicine.
When COVID hit, the DEA waived this requirement under federal emergency powers. As of February 2026, that waiver remains in effect (extended through December 31, 2025, with likely further extensions). This means:
The DEA has proposed permanent rules that would impose some restrictions—potentially requiring an in-person visit after 30 days, or allowing exceptions if another provider saw the patient in person within 12 months. But as of mid-2026, those proposals haven’t been finalized. Psychiatrists and PMHNPs can continue prescribing controlled meds via telehealth under the current federal waiver.
Key point for psychiatrists: You have full prescribing authority in all 50 states. If federal law allows remote controlled-substance prescribing, you can do it—unless a specific state law prohibits it (which we’ll cover below).
Key point for PMHNPs: Your authority depends entirely on state scope-of-practice laws. Even if federal law allows teleprescribing, you might still need physician oversight or collaboration in certain states.
While federal law sets the baseline, state laws determine who can prescribe what, and under what conditions. This is especially critical for PMHNPs, whose prescribing authority varies wildly by state.
Psychiatrists: Full independent prescribing. You can initiate controlled substances via telehealth as long as you conduct a ‘good faith exam’—and California explicitly recognizes video visits as meeting that standard.
PMHNPs: California is transitioning to full practice authority under AB 890 (2020). As of 2023, experienced NPs (3+ years) can practice without physician supervision in collaborative settings (‘103 NPs’). Starting January 1, 2026, those NPs can apply for full independence (‘104 NPs’), meaning no physician oversight required.
Until then, newer PMHNPs must work under standardized procedures with a collaborating physician. For prescribing controlled substances, that physician must explicitly delegate authority in a written protocol.
Telehealth specifics: California has strong telehealth parity laws (AB 744). Private insurers must reimburse telehealth at the same rate as in-person for mental health services. You must check CURES (California’s prescription monitoring database) before prescribing Schedule II–IV drugs.
Bottom line: If you’re an experienced California PMHNP, you’re about to get a lot more autonomy. If you’re a newer NP, find a psychiatrist willing to collaborate—or join a platform like Klarity that provides that structure.
Psychiatrists: Full independent prescribing. You can prescribe any psychiatric medication via telehealth, including controlled substances, as long as the standard of care is met.
PMHNPs: Texas is one of the most restrictive states for NPs. You cannot prescribe anything independently—all prescribing requires a Prescriptive Authority Agreement with a Texas-licensed physician.
Even with delegation, Texas law prohibits NPs from prescribing Schedule II controlled substances in outpatient settings (with narrow exceptions for terminal illness or hospice care). This means Texas PMHNPs generally cannot prescribe stimulants for ADHD on their own—the collaborating physician must write those scripts.
You can prescribe Schedule III–V meds (including some anxiety meds and certain ADHD non-stimulants like Strattera) under delegation.
Telehealth specifics: Texas allows telemedicine prescribing if the encounter meets in-person standards (real-time audio-visual). The state prohibits teleprescribing Schedule II opioids for chronic pain, but mental health treatment is explicitly allowed.
Texas also requires:
Bottom line: Texas PMHNPs operate more like physician extenders than independent providers. If you’re a psychiatrist, you have free rein. If you’re an NP, expect significant administrative overhead and find a collaborating psychiatrist who understands telehealth.
Psychiatrists: Full independent prescribing. Florida has one of the most permissive telehealth laws in the country: you can prescribe controlled substances via telehealth for psychiatric treatment without any additional restrictions (Florida Statutes 456.47).
PMHNPs: Florida passed HB 607 (2020), which allows ‘Autonomous APRNs’ in primary care (family medicine, internal medicine, pediatrics). Psychiatric NPs were explicitly excluded from this autonomy.
PMHNPs must practice under a supervising physician’s protocol. However, there’s a carve-out: if you’re a ‘psychiatric nurse’ (MSN/DNP in psych nursing + 2 years post-grad experience under a psychiatrist), you can prescribe psychotropic controlled substances in collaboration with a psychiatrist, and you’re exempt from Florida’s 7-day limit on Schedule II prescriptions.
Telehealth specifics: Florida’s law allows controlled-substance prescribing via telehealth for mental health treatment—a huge advantage. Out-of-state providers can register to provide telehealth to Florida patients, but out-of-state NPs cannot prescribe controlled substances under that registration.
Bottom line: Florida psychiatrists have one of the most telehealth-friendly environments in the country. PMHNPs need a collaborating psychiatrist but can manage psychiatric meds (including controlled substances) once they meet the ‘psychiatric nurse’ criteria.
Psychiatrists: Full independent prescribing. New York recently finalized regulations aligning state controlled-substance prescribing rules with federal telehealth waivers, so you can prescribe via video without state-level obstacles.
PMHNPs: New York’s NP Modernization Act (made permanent in 2022) allows NPs to practice independently after completing 3,600 hours (roughly 2 years) under a collaborative agreement.
During those first 3,600 hours, you must have a written practice agreement with a physician (usually a psychiatrist for PMHNPs) outlining your scope and protocols. After that, you attest to having a ‘collaborative relationship’ with physicians (informal consultative ties), but no formal supervision or chart review is required.
Telehealth specifics: New York has strong telehealth support. All insurers must cover telehealth. The state requires e-prescribing for all controlled substances (no paper scripts) and mandates checking the I-STOP PMP registry before prescribing Schedule II–IV drugs.
Bottom line: If you’re an experienced New York PMHNP (2+ years), you have full practice authority. If you’re newer, find a collaborating psychiatrist—but know that independence is on a clear timeline.
Psychiatrists: Full independent prescribing.
PMHNPs: Pennsylvania requires a collaborative agreement with a physician for the entirety of your practice. There is no pathway to independence yet, though legislation (SB 25) has been introduced multiple times.
Your collaborative agreement must detail which drugs you can prescribe. Pennsylvania allows NPs to prescribe Schedule II–V controlled substances if the collaborating physician delegates it, but with restrictions:
Telehealth specifics: Pennsylvania has no unique telehealth prescribing restrictions beyond federal law. Medicaid and major insurers cover telepsychiatry, though the state doesn’t yet have a comprehensive telehealth parity statute.
Bottom line: Pennsylvania PMHNPs face ongoing supervision requirements. If FPA legislation passes (likely by 2026–27), this changes overnight. Until then, expect physician oversight.
Psychiatrists: Full independent prescribing.
PMHNPs: Illinois allows NPs to apply for Full Practice Authority after completing 4,000 hours of clinical practice under physician collaboration + 250 hours of continuing education in pharmacology.
Until you achieve FPA licensure, you must have a Written Collaborative Agreement with a physician. The collaborating physician’s name must appear on prescriptions (signaling delegation). Once you have FPA, you get a new license designation and can prescribe controlled substances independently (you must apply for a mid-level practitioner controlled substance license).
Telehealth specifics: Illinois enacted strong telehealth parity laws. Private insurers must reimburse telehealth at the same rate as in-person through at least 2027 for behavioral health. Illinois also uniquely allows clinical psychologists with specialized training to prescribe a limited formulary of mental health meds under psychiatrist supervision.
Bottom line: Illinois offers a clear path to independence for PMHNPs—plan for 2–3 years of collaboration before flying solo. Psychiatrists have full authority from day one.
Here’s something many providers don’t know: Medicare and some state Medicaid programs now reimburse for audio-only telehealth for mental health services.
This was a pandemic-era flexibility aimed at closing the digital divide (many patients lack reliable internet or smartphones with video). As of 2026, Medicare pays for certain mental health services delivered via phone at the same rate as an office visit—as long as the patient cannot access video.
For psychiatrists, this means:
State rules vary: Illinois and Massachusetts require private insurers to cover audio-only mental health at parity. Other states (like Texas and Florida) don’t explicitly mandate it, but many insurers voluntarily cover it.
Controlled substances caveat: While some states allow audio-only visits for general psychiatric care, federal DEA rules are less clear on prescribing controlled substances via phone-only. Most conservative interpretation: use video for any visit where you’re prescribing stimulants, benzodiazepines, or buprenorphine. Use audio-only for non-controlled med checks (antidepressants, antipsychotics, mood stabilizers).
Short answer: Yes, in most cases.
Thanks to COVID-era policy changes that have largely become permanent, Medicare and most private insurers reimburse telepsychiatry at the same rate as in-person visits.
Here’s what Medicare pays psychiatrists for common medication management visits:
| CPT Code | Service Description | Medicare Rate (2026) |
|---|---|---|
| 90792 | Initial psychiatric eval w/ medication management (60 min) | ~$173 |
| 99213 | Established patient, 15-min med check | ~$95 |
| 99214 | Established patient, 25-min med check | ~$136 |
| 99215 | Established patient, 40-min med check (complex) | ~$192 |
PMHNPs receive 85% of these rates when billing under their own NPI. If you bill ‘incident to’ a physician (in-office, under direct supervision), you’d get 100%—but this doesn’t apply to telehealth since the physician isn’t physically present.
Commercial insurers typically pay more than Medicare—often 120–150% of Medicare rates in high-cost areas. For example, a psychiatrist in Manhattan might get $150 for a 99213 (vs. Medicare’s $95).
Telehealth parity laws in over 40 states require insurers to cover telehealth at the same rate as in-person for mental health services. States with strong parity mandates include:
Medicaid rates are typically lower than Medicare but have improved for behavioral health in recent years. Many state Medicaids (New York, Pennsylvania, Illinois) reimburse telepsychiatry at the same rate as face-to-face.
Here’s the part nobody talks about: acquiring psychiatric patients through DIY marketing is expensive and time-consuming.
Let’s break down the real costs:
Google Ads for mental health keywords:
SEO (building your own practice website):
Directory listings (Psychology Today, Zocdoc):
Reality check: If you’re spending $3,000–$5,000/month on marketing with uncertain results, you’re gambling. You might acquire 10–15 new patients per month—or you might acquire none while still paying agency fees.
Platforms like Klarity Health use a pay-per-appointment model. You don’t pay for ads, clicks, or directory fees. You pay a standard listing fee per new patient lead who books with you.
Key advantages:
Economic reality: Instead of spending $3,000–$5,000/month on marketing with unpredictable results, you pay only when a qualified patient books with you. That’s guaranteed ROI vs. gambling on marketing channels.
Example: A psychiatrist on Klarity might pay a listing fee per new patient (similar to Zocdoc’s per-booking model, but without the monthly subscription). If you see 20 new patients a month, you pay for 20 leads—and you’ve already seen the patients, so there’s no no-show risk or unqualified leads wasting your time.
Beyond the hard costs, consider:
For most providers, especially those starting out or scaling, a platform that handles patient acquisition removes the risk entirely.
If you’re a PMHNP in a state requiring physician collaboration (Texas, Florida, Pennsylvania, early-career Illinois), here’s what those agreements typically entail:
Your agreement must detail:
Many states mandate periodic oversight:
Some states require filing the collaborative agreement with the board of nursing (e.g., Kentucky). Others just require you to have it on file and available upon request.
Every state requires checking the PMP before prescribing controlled substances:
Your notes should include:
The DEA’s permanent telemedicine prescribing rules were expected by late 2024. As of February 2026, they’re still in proposed form. Monitor:
You must hold an active medical or nursing license in the state where the patient is located at the time of the consult. Consider:
Q: Can I prescribe Adderall or other stimulants via telehealth in 2026?
A: Yes, under current federal DEA waivers (extended through December 2025, likely continuing). You must conduct a legitimate video evaluation, and the patient must be located in a state where you’re licensed. State-specific restrictions apply—for example, Texas PMHNPs generally cannot prescribe Schedule II stimulants even via telehealth.
Q: Do I need to see a patient in person before prescribing controlled substances?
A: Not currently, under federal telehealth flexibilities. The DEA’s proposed permanent rules may eventually require an in-person visit within 30 days or other conditions, but those rules haven’t been finalized as of February 2026.
Q: Can PMHNPs prescribe controlled substances independently?
A: It depends on the state. In full practice authority states (e.g., Washington, Oregon, experienced NPs in New York and Illinois), yes. In restricted states (Texas, Florida, Pennsylvania), you need physician delegation—and some states (Texas) prohibit NP prescribing of Schedule II entirely in outpatient settings.
Q: Does telehealth pay as well as in-person?
A: Yes, in most cases. Medicare and the majority of private insurers reimburse telepsychiatry at parity with in-person visits due to permanent policy changes post-COVID. Some states without parity mandates (like Texas) still see voluntary parity from major insurers.
Q: Can I prescribe via phone (audio-only) instead of video?
A: For general psychiatric medications (antidepressants, antipsychotics), yes—Medicare and some state Medicaid programs reimburse audio-only mental health visits. For controlled substances, it’s safer to use video to comply with federal and state telemedicine standards.
Q: What happens if the DEA changes the rules?
A: Stay informed. If new DEA rules require an in-person visit after an initial telehealth prescription, you’ll need to either see patients face-to-face or arrange for another provider to conduct that visit. Most expect any final rules will include reasonable exceptions for ongoing psychiatric care.
Q: How do I find a collaborating physician as a PMHNP?
A: Many telehealth platforms (like Klarity Health) provide collaborating psychiatrists as part of their infrastructure. Alternatively, search professional networks (state NP associations, LinkedIn groups), or negotiate directly with psychiatrists in your area. Be prepared to pay $500–$2,000/month for collaboration (rates vary by region and involvement level).
If you’re a psychiatrist or PMHNP evaluating telehealth platforms, here’s the bottom line:
Klarity Health removes the patient acquisition risk.
Instead of spending thousands per month on marketing with uncertain results, you pay only when a qualified patient books with you. That means:
For PMHNPs in restricted states: Klarity can provide the collaborative physician oversight required by law—removing a major barrier to starting or scaling your practice.
For psychiatrists: You focus on clinical care, not marketing. You control your schedule, see patients you want to see, and get paid without the gamble of DIY marketing.
The math is simple: Would you rather spend $3,000–$5,000/month on marketing hoping to fill your schedule, or pay per patient actually seen and know your ROI upfront?
Explore Klarity Health’s provider network to see how we help psychiatrists and PMHNPs build sustainable, compliant telehealth practices—without the marketing risk.
Find the right provider for your needs — select your state to find expert care near you.